P1889
INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis TrialEfficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus BivalirudinEffect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive StrategyThe INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)Should Integrilin be an Integral Part of Adjunctive Therapy in Patients Undergoing Primary PCI for ST-Elevation MI?Multi-arm Optimization of Stroke ThrombolysisBRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary InterventionShortened Aggrastat® Versus Integrilin in Percutaneous Coronary InterventionStudy of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated InfusionIntegrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe SepsisMinimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioXEffectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI PatientsA Safety Study of Eptifibatide in Patients With Sickle Cell DiseaseEptifibatide and ST Segment Resolution Following Primary PCIA Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart AttacksEptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)Pharmacologic Treatment of Myocardial Ischemia Detected by Intracoronary ECGClinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-upStudy of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic StrokeStudy of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary SyndromeRandomized Study of Aspirin Resistant Patients Undergoing AngioplastySafety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI)Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) TrialEARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)Crushed Ticagrelor Versus Eptifibatide Bolus + ClopidogrelCo-administration of Iloprost and Eptifibatide in Septic Shock Patients
P4844
Q61915070-DD6489A7-6470-4A2B-8335-15E264D4D1FDQ61921410-9807F121-A047-493B-A3D4-FE0C7AB63106Q61933417-7C3DA87F-00E6-471A-A785-61C58DA5F8C1Q61938097-6C9EC06E-0BFB-4AA2-9251-88EE98F79B62Q61966518-8E5ED92A-9FC9-4FD2-9571-557F75707130Q61970026-3F1C146B-36AF-4C7A-9BC5-0677B18010F7Q62035532-753E16EB-F01B-4A63-9ADD-AFAA9EE9069FQ62105130-5A1CF091-B714-4CCF-8F8A-DF57E414E343Q63319828-A1E85BEC-E56A-4DE8-A38F-AD13A9CF569AQ64352811-B8178B6C-8906-4946-B005-FACB9ABF43D9Q64622488-5F47E27A-615A-49B1-B2BD-EDEE2FC8B08EQ64646807-E2D6D2A1-435B-434B-B2A1-0CF69F1FAC7AQ64648105-F063A194-61A3-4D09-B75C-081FD79EBD96Q64665449-669C7371-4459-467C-84F3-2098567BD973Q64694918-8B5ECC4C-4B87-470A-9A32-4A8EF3DAB294Q64697102-C97FADDA-5A45-49F7-8C1E-8CD31176E745Q64717815-3BE47DE2-2977-4569-B713-3806F68F68CAQ64794485-B55B98A1-D693-4AFB-ADCD-A62AEC38100BQ64805200-B3BEE0BA-E702-40BF-88FC-A552FBD03581Q65365876-A82CFFCF-7B78-4D1B-8D33-AA4D100AECE8Q65378806-6F4162C6-E80C-42E6-9439-BEF5E7E61B1DQ65390813-58C44709-6D2D-442B-B73B-B2EEF2CCB189Q65539148-726198C2-78E9-4488-BEA0-E1FAC54E337BQ65541293-9D09C6F3-437E-4EB5-8A01-559D8EBC6C13Q65541435-DD26AA50-6659-4133-9D94-69FC1518FA3EQ66033180-83ECDCF9-662A-4D93-BE3A-5F4423BD2864Q66036217-79E5FADC-C87A-4F16-87F1-5039AC0E9428Q66081792-6CF25D2A-A19C-45E8-8F57-4E290325C450Q67132913-69E63CF8-F648-404B-AC25-D5F9AD6EC66B
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Eptifibatid
@sh
Eptifibatid
@sr
Eptifibatide
@it
Eptifibatide
@nl
Eptifibatide
@vi
Eptyfibatyd
@pl
eptiffibatid
@cy
eptifibatid
@nn
eptifibatide
@en
eptifibatide
@fr
type
label
Eptifibatid
@sh
Eptifibatid
@sr
Eptifibatide
@it
Eptifibatide
@nl
Eptifibatide
@vi
Eptyfibatyd
@pl
eptiffibatid
@cy
eptifibatid
@nn
eptifibatide
@en
eptifibatide
@fr
altLabel
C35H49N11O9S2
@it
C68-22
@cy
C68-22
@en
EPTIFIBATIDE
@cy
EPTIFIBATIDE
@en
Eptifibatid
@pl
Eptifibatida
@pt
Integrelin®
@cy
Integrelin®
@en
Integrilin
@fr
prefLabel
Eptifibatid
@sh
Eptifibatid
@sr
Eptifibatide
@it
Eptifibatide
@nl
Eptifibatide
@vi
Eptyfibatyd
@pl
eptiffibatid
@cy
eptifibatid
@nn
eptifibatide
@en
eptifibatide
@fr
P2175
P31
P486
P592
P6366
P646
P661
P662
P665
P683
P1579
P2017
C1C[C@H]2C(=O)N[C@@H](CSSCCC(= ...... C43)CC(=O)O)CCCCN=C(N)N)C(=O)N